We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+6.18%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$21.9B
AUM Growth
+$1.56B
(+7.6%)
Cap. Flow
+$486M
Cap. Flow
% of AUM
2.22%
Top 10 Holdings %
Top 10 Hldgs %
19.94%
Holding
3,346
New
196
Increased
1,490
Reduced
1,397
Closed
181
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$43.6M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$39.6M |
| 3 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$36.1M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$35.4M |
| 5 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$32.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$41.5M |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$36.1M |
| 3 |
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
|
+$27.3M |
| 4 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$22.9M |
| 5 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$22.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.43% |
| 2 | Financials | 4.62% |
| 3 | Consumer Discretionary | 4.22% |
| 4 | Healthcare | 3.87% |
| 5 | Industrials | 2.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIK
3076
Credit Suisse Asset Management Income Fund
CIK
$134M
| $54K | ﹤0.01% |
18,351
-2,649
| -13% | -$7.32K |
|
3077
B2Gold
BTG
$6.7B
| $52K | ﹤0.01% |
14,653
+246
| +2% | +$963 |
|
|
RJET
3078
Republic Airways Holdings
RJET
$964M
| $51K | ﹤0.01% |
1,332
+20
| +2% | +$613 |
|
3079
US Gold Corp
USAU
$249M
| $51K | ﹤0.01% |
+11,410
| New | +$50.2K |
|
|
CHMI
3080
Cherry Hill Mortgage Investment Corp
CHMI
$108M
| $50K | ﹤0.01% |
10,277
-435
| -4% | -$2.24K |
|
3081
Rekor Systems
REKR
$97.6M
| $50K | ﹤0.01% |
28,189
+8,500
| +43% | +$11.8K |
|
|
PGRU
3082
DELISTED
PropertyGuru Group Limited
PGRU
| $50K | ﹤0.01% |
11,175
| – | – |
|
3083
Diana Shipping
DSX
$307M
| $48K | ﹤0.01% |
16,473
+2,961
| +22% | +$9.07K |
|
3084
Playboy Inc
PLBY
$149M
| $48K | ﹤0.01% |
28,552
-8,880
| -24% | -$15K |
|
|
EDD
3085
Morgan Stanley Emerging Markets Domestic Debt Fund
EDD
$374M
| $47K | ﹤0.01% |
10,000
-2,000
| -17% | -$9.44K |
|
|
CGC
3086
Canopy Growth
CGC
$426M
| $46K | ﹤0.01% |
11,941
-810
| -6% | -$8.5K |
|
|
PHX
3087
DELISTED
PHX Minerals
PHX
| $44K | ﹤0.01% |
14,053
-1,183
| -8% | -$3.36K |
|
|
AMRN
3088
Amarin Corp
AMRN
$299M
| $43K | ﹤0.01% |
1,790
-75
| -4% | -$1.93K |
|
3089
ADMA Biologics
ADMA
$2.11B
| $42K | ﹤0.01% |
11,428
-10,000
| -47% | -$37.1K |
|
3090
ImmunityBio
IBRX
$8.11B
| $42K | ﹤0.01% |
14,950
+1,000
| +7% | +$2.83K |
|
3091
Opendoor
OPEN
$3.54B
| $42K | ﹤0.01% |
10,889
-13,426
| -55% | -$29.1K |
|
3092
Phio Pharmaceuticals
PHIO
$12.7M
| $41K | ﹤0.01% |
1,581
| – | – |
|
3093
Planet Labs
PL
$8.82B
| $41K | ﹤0.01% |
12,712
+60
| +0.5% | +$238 |
|
3094
Paramount Gold Nevada
PZG
$127M
| $41K | ﹤0.01% |
130,540
-10,658
| -8% | -$3.45K |
|
3095
Douglas Elliman
DOUG
$183M
| $40K | ﹤0.01% |
17,888
+3,987
| +29% | +$10.9K |
|
|
ILPT
3096
Industrial Logistics Properties Trust
ILPT
$611M
| $40K | ﹤0.01% |
12,124
+46
| +0.4% | +$103 |
|
|
SGMO
3097
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $40K | ﹤0.01% |
30,854
| – | – |
|
|
TGB
3098
Trekor Metals
TGB
$3.08B
| $40K | ﹤0.01% |
27,780
-100
| -0.4% | -$150 |
|
3099
Telos
TLS
$344M
| $39K | ﹤0.01% |
+15,138
| New | +$35.9K |
|
|
LEV
3100
DELISTED
The Lion Electric Company
LEV
| $39K | ﹤0.01% |
21,219
+3,795
| +22% | +$7.67K |
|
Similar funds
LP
HF
Cambridge Investment Research Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Cambridge Investment Research Advisors held 3,346 positions worth $21.9B, up 7.6% from $20.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Cambridge Investment Research Advisors's Q2 2023 filing shows 196 new, 1,490 increased, 1,397 reduced and 181 closed positions. Its largest new stake was BondBloxx Bloomberg Six Month Target Duration US Treasury ETF: 325,174 shares worth $16.3M. The largest sale was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $41.5M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.4% a quarter earlier, followed by Financials and Consumer Discretionary.
- Cambridge Investment Research Advisors's largest Q2 2023 buy was BondBloxx Bloomberg Six Month Target Duration US Treasury ETF: 325,174 shares worth $16.3M.
- Cambridge Investment Research Advisors added most to Invesco QQQ Trust in Q2 2023, an estimated $43.6M increase.
- Cambridge Investment Research Advisors's biggest Q2 2023 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $41.5M.
- Cambridge Investment Research Advisors fully exited AllianzIM U.S. Equity Buffer10 Jul ETF in Q2 2023, selling an estimated $9.73M.
- Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $21.9B portfolio in Q2 2023.
- Cambridge Investment Research Advisors opened 196 new positions and closed 181 in Q2 2023.
- Cambridge Investment Research Advisors's portfolio value rose 7.6% quarter-over-quarter to $21.9B.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2023, filed 13 Jul 2023.